FindTrial
Sign In

Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention

Real-world EValuation of the antithrombotic thErapy And clinicaL outcomes for the patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention - REVEAL AF-PCI Registry

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022004
Enrollment
5000
Registered
2016-05-01
Start date
2015-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation Coronary Artery Disease

Interventions

None listed

Sponsors

Department of Clinical Epidemiology, Hyogo College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients treated by percutaneous coronary intervention (PCI). 2. Patients diagnosed as atrial fibrillation at the time of index PCI.

Exclusion criteria

Exclusion criteria: Patients who denied participation.

Design outcomes

Primary

MeasureTime frame
Composite of death, myocardial infarction, stent thrombosis, stroke, and systemic embolism at 1-year from the index percutaneous coronary intervention.—

Countries

Japan

Contacts

Public ContactToshiaki Toyota

Kyoto University Graduate School of Medicine Department of Cardiovascular Medicine

totoyota@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026